Correspondence on "Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation" by Thompson et al
- PMID: 34113004
- DOI: 10.1038/s41436-021-01235-5
Correspondence on "Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation" by Thompson et al
Comment in
-
Response to Suay-Corredera et al.Genet Med. 2021 Oct;23(10):2011-2012. doi: 10.1038/s41436-021-01236-4. Epub 2021 Jun 16. Genet Med. 2021. PMID: 34135487 No abstract available.
Comment on
-
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation.Genet Med. 2021 Jul;23(7):1281-1287. doi: 10.1038/s41436-021-01134-9. Epub 2021 Mar 29. Genet Med. 2021. PMID: 33782553 Free PMC article.
References
-
- Marian Ali, J. & Braunwald, E. Hypertrophic cardiomyopathy. Circ. Res. 121, 749–770 (2017). - DOI
-
- Semsarian, C. & Ingles, J. in Hypertrophic Cardiomyopathy (ed Naidu, S. S). Genetics of HCM and role of genetic testing. (Springer-Verlag, London, 2015).
-
- Thompson, A. D. et al. Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation. Genet. Med. https://doi.org/10.1038/s41436-021-01134-9 (2021).
-
- Ababou, A. et al. Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1. J. Mol. Biol. 384, 615–630 (2008). - DOI
-
- Smelter, D. F., Lange, W. J. D., Cai, W., Ge, Y. & Ralphe, J. C. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability. Am J Physioll Heart Circ Physiol 314, H1179–H1191 (2018). - DOI